As global pharmaceutical regulation evolves, “reliance” has become a key strategy for improving review efficiency and accelerating access to innovative drugs. The World Health Organization (WHO) highlights that strong regulatory systems rely not only on capacity and consistency but also on fostering cooperation through transparency and predictability. According to the WHO’s Good Regulatory Practices (GRP) … Cross-Border Trust and Transparency: The New Landscape of Bridging the Regulatory Review in the Asia-Pacific Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.